Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)
China · Delayed Price · Currency is CNY 17.57
-0.25 (-1.40%)
Jun 1, 2026, 3:00 PM CST
SHA:688658 Revenue
Youcare Pharmaceutical Group had revenue of 556.04M CNY in the quarter ending March 31, 2026, a decrease of -3.70%. This brings the company's revenue in the last twelve months to 2.42B, down -28.48% year-over-year. In the year 2025, Youcare Pharmaceutical Group had annual revenue of 2.45B, down -35.30%.
Revenue (ttm)
2.42B
Revenue Growth
-28.48%
P/S Ratio
3.22
Revenue / Employee
844.86K
Employees
2,870
Market Cap
7.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.45B | -1.33B | -35.30% |
| Dec 31, 2024 | 3.78B | -415.42M | -9.90% |
| Dec 31, 2023 | 4.20B | -345.64M | -7.61% |
| Dec 31, 2022 | 4.54B | -423.78M | -8.53% |
| Dec 31, 2021 | 4.97B | 626.78M | 14.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 15.60B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.84B |
| Aurisco Pharmaceutical | 1.68B |
| Nanjing Vazyme Biotech | 1.41B |
| Jiangxi Fushine Pharmaceutical | 1.31B |
| Shanghai Medicilon | 1.26B |
| Bio-Thera Solutions | 980.25M |
| GemPharmatech | 830.61M |